InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Recknor Chris P, 首席执行官. Director active across 1 company, notably CytoDyn Inc.. Cumulatively, 2 reports have been published. Activity tracked since 6 August 2021. The latest transaction was disclosed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Recknor Chris P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
12,950 股0Common StockSEC:0001104659-22-069300:0
19,384 股0Common stockSEC:0000899243-21-032385:0
2 条申报中的 2 条
About Recknor Chris P
Chris P. Recknor is the Chief Operating Officer at CytoDyn Inc. He is responsible for overseeing the company's operations, ensuring efficiency and process optimization. With a strong background in the biopharmaceutical sector, he plays a key role in implementing operational strategy.
